Form 4: DHC CEO Plans 20,000 Share Purchase

Diversified Healthcare Trust's President and CEO, Christopher J. Bilotto, has filed a Form 4 indicating a planned purchase of 20,000 common shares on December 15, 2025, at an average price of $4.886.

Summary

• Christopher J. Bilotto, President and CEO, and a Director of Diversified Healthcare Trust (NASDAQ: DHC), plans to acquire 20,000 common shares of beneficial interest.
• The planned transaction date for this acquisition is December 15, 2025.
• The shares are to be purchased at a weighted average price of $4.886 per share, with individual transaction prices ranging from $4.88 to $4.89.
• This transaction is being made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
• Following this planned transaction, Mr. Bilotto's beneficial ownership will total 266,284.908 common shares.
• The total beneficial ownership includes 385.018 shares acquired under a dividend reinvestment plan since Mr. Bilotto's last Section 16 filing.

Sentiment

Score: 8

Explanation: The planned insider purchase by the CEO, especially under a Rule 10b5-1 plan, indicates strong confidence in the company's future performance and valuation. This is generally viewed as a positive signal by the market.

Positives

• The planned purchase of 20,000 shares by the President and CEO signals strong management confidence in the company's future prospects and valuation.
• The transaction is structured under a Rule 10b5-1(c) plan, indicating a pre-planned investment decision rather than a reaction to immediate market movements, which can suggest a long-term positive outlook.

Future Outlook

The planned insider purchase by the CEO suggests a positive future outlook for Diversified Healthcare Trust, as management is committing personal capital to increase their stake in the company at the stated price.

Industry Context

Insider buying in the healthcare REIT sector can be a significant indicator, especially when executed by a CEO. It suggests that despite potential industry-specific challenges or broader economic headwinds, the executive believes the company's current valuation is attractive and expects future appreciation. This action could be seen as a vote of confidence in the company's strategy and asset portfolio within the healthcare real estate market.

Corporate Governance

Related Party Transactions

• Christopher J. Bilotto, President and CEO, and a Director, is planning to purchase 20,000 common shares of Diversified Healthcare Trust, which constitutes an insider transaction.

Stakeholder Impact

• Shareholders may view the CEO's planned share purchase as a positive signal, potentially increasing investor confidence and demand for the stock.
• Employees might interpret the CEO's investment as a sign of stability and belief in the company's long-term success.

Key Dates

Recommendation

The planned purchase of a significant number of shares by the President and CEO, Christopher J. Bilotto, at a specific price, especially under a Rule 10b5-1 plan, is a strong indicator of management's confidence in the company's intrinsic value and future prospects. Insider buying often precedes positive company performance, suggesting that the stock may be undervalued at current levels. This action provides a compelling reason for investors to consider a 'buy' position, aligning with management's conviction.

Keywords

DHC, Diversified Healthcare Trust, Insider Trading, Share Purchase, CEO, Common Shares, Form 4, Rule 10b5-1, Healthcare REIT